Health | Indo-Asian News Service | Wednesday February 17, 2016
Results of a recent clinical study have shown that an anti-cancer drug that triggers cell death in various tumour types, may have clinical potential for some blood cancers including mantel cell lymphoma (MCL) and acute myeloid leukemia (AML).
www.ndtv.com